The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jul. 25, 2023

Filed:

May. 14, 2020
Applicant:

Massachusetts Mutual Life Insurance Company, Springfield, MA (US);

Inventors:

Marc Maier, Springfield, MA (US);

Shanshan Li, Springfield, MA (US);

Hayley Carlotto, Springfield, MA (US);

Indra Kumar, Springfield, MA (US);

Assignee:
Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
G06Q 20/00 (2012.01); G16H 50/20 (2018.01); G16H 50/30 (2018.01); G16H 50/70 (2018.01); G06N 5/045 (2023.01); G06N 20/00 (2019.01); G06Q 10/10 (2023.01); G16H 20/10 (2018.01); G06Q 40/08 (2012.01); G06Q 40/03 (2023.01);
U.S. Cl.
CPC ...
G16H 50/20 (2018.01); G06N 5/045 (2013.01); G06N 20/00 (2019.01); G06Q 10/10 (2013.01); G06Q 40/03 (2023.01); G06Q 40/08 (2013.01); G16H 20/10 (2018.01); G16H 50/30 (2018.01); G16H 50/70 (2018.01);
Abstract

A suite of fluidless predictive machine learning models includes a fluidless mortality module, smoking propensity model, and prescription fills model. The fluidless machine learning models are trained against a corpus of historical underwriting applications of a sponsoring enterprise, including clinical data of historical applicants. Fluidless models are trained by application of a random forest ensemble including survival, regression, and classification models. The trained models produce high-resolution, individual mortality scores. A fluidless underwriting protocol runs these predictive models to assess mortality risk and other risk attributes of a fluidless application that excludes clinical data to determine whether to present an accelerated underwriting offer. If any of the fluidless predictive models determines a high risk target, the applicant is required to submit clinical data, and an explanation model generates an explanation file for user interpretability of any high risk model prediction and the adverse underwriting decision.


Find Patent Forward Citations

Loading…